Skip to main content

Main menu

  • Home
  • Content
    • First Release
    • Current
    • Archives
    • Collections
    • Audiovisual Rheum
    • COVID-19 and Rheumatology
    • 50th Volume Reprints
  • Resources
    • Guide for Authors
    • Submit Manuscript
    • Payment
    • Reviewers
    • Advertisers
    • Classified Ads
    • Reprints and Translations
    • Permissions
    • Meetings
    • FAQ
    • Policies
  • Subscribers
    • Subscription Information
    • Purchase Subscription
    • Your Account
    • Terms and Conditions
  • About Us
    • About Us
    • Editorial Board
    • Letter from the Editor
    • Duncan A. Gordon Award
    • Privacy/GDPR Policy
    • Accessibility
  • Contact Us
  • JRheum Supplements
  • Services

User menu

  • My Cart
  • Log In

Search

  • Advanced search
The Journal of Rheumatology
  • JRheum Supplements
  • Services
  • My Cart
  • Log In
The Journal of Rheumatology

Advanced Search

  • Home
  • Content
    • First Release
    • Current
    • Archives
    • Collections
    • Audiovisual Rheum
    • COVID-19 and Rheumatology
    • 50th Volume Reprints
  • Resources
    • Guide for Authors
    • Submit Manuscript
    • Payment
    • Reviewers
    • Advertisers
    • Classified Ads
    • Reprints and Translations
    • Permissions
    • Meetings
    • FAQ
    • Policies
  • Subscribers
    • Subscription Information
    • Purchase Subscription
    • Your Account
    • Terms and Conditions
  • About Us
    • About Us
    • Editorial Board
    • Letter from the Editor
    • Duncan A. Gordon Award
    • Privacy/GDPR Policy
    • Accessibility
  • Contact Us
  • Follow jrheum on Twitter
  • Visit jrheum on Facebook
  • Follow jrheum on LinkedIn
  • Follow jrheum on YouTube
  • Follow jrheum on Instagram
  • Follow jrheum on RSS

Table of Contents

March 01, 2006; Volume 33,Issue 3
  • You have access
    Outcome issues for rheumatoid arthritis: what do we have and what do we want?
    Daniel A Albert
    The Journal of Rheumatology March 1 2006, 33 (3) 441-442;
  • You have access
    Management of whiplash-associated disorders--revisiting Quebec.
    Robert Ferrari
    The Journal of Rheumatology March 1 2006, 33 (3) 443-444;
  • You have access
    The role of inflammatory cytokines in the pathogenesis of systemic lupus erythematosus-related atherosclerosis: a novel target for treatment?
    Ora Shovman, Boris Gilburd and Yehuda Shoenfeld
    The Journal of Rheumatology March 1 2006, 33 (3) 445-447;
  • You have access
    Saving time and improving care with a multidimensional health assessment questionnaire: 10 practical considerations.
    Theodore Pincus, Yusuf Yazici and Martin Bergman
    The Journal of Rheumatology March 1 2006, 33 (3) 448-454;
  • You have access
    Effects of viral interleukin 10 introduced by in vivo electroporation on arthrogen-induced arthritis in mice.
    Takeshi Kuroda, Hiroki Maruyama, Masaaki Shimotori, Noboru Higuchi, Shigemi Kameda, Hideaki Tahara, Jun-Ichi Miyazaki and Fumitake Gejyo
    The Journal of Rheumatology March 1 2006, 33 (3) 455-462;
  • You have access
    Simvastatin inhibits production of interleukin 6 (IL-6) and IL-8 and cell proliferation induced by tumor necrosis factor-alpha in fibroblast-like synoviocytes from patients with rheumatoid arthritis.
    Kazuhiro Yokota, Takashi Miyazaki, Motoharu Hirano, Yuji Akiyama and Toshihide Mimura
    The Journal of Rheumatology March 1 2006, 33 (3) 463-471;
  • You have access
    Quinacrine but not chloroquine inhibits PMA induced upregulation of matrix metalloproteinases in leukocytes: quinacrine acts at the transcriptional level through a PLA2-independent mechanism.
    Karl M Stuhlmeier and Christine Pollaschek
    The Journal of Rheumatology March 1 2006, 33 (3) 472-480;
  • You have access
    Splitting high-dose oral methotrexate improves bioavailability: a pharmacokinetic study in patients with rheumatoid arthritis.
    Monique Hoekstra, Cees Haagsma, Cees Neef, Johannes Proost, Antonius Knuif and Mart van de Laar
    The Journal of Rheumatology March 1 2006, 33 (3) 481-485;
  • You have access
    Combination of cyclosporine and leflunomide versus single therapy in severe rheumatoid arthritis.
    George Karanikolas, Dionisios Charalambopoulos, Alexandros Andrianakos, Christos Antoniades and Nikolaos Katsilambros
    The Journal of Rheumatology March 1 2006, 33 (3) 486-489;
  • You have access
    Short-term outcome after anti-tumor necrosis factor-alpha therapy in rheumatoid arthritis: do we need to revise our assessment criteria?
    Yasser El Miedany, Sally S Youssef and Maha El Gaafary
    The Journal of Rheumatology March 1 2006, 33 (3) 490-497;
  • You have access
    Anti-cyclic citrullinated protein antibodies as a predictor of response to anti-tumor necrosis factor-alpha therapy in patients with rheumatoid arthritis.
    Yolanda Braun-Moscovici, Doron Markovits, Oren Zinder, Daniel Schapira, Alexander Rozin, Marc Ehrenburg, Lena Dain, Erica Hoffer, A Menahem Nahir and Alexandra Balbir-Gurman
    The Journal of Rheumatology March 1 2006, 33 (3) 497-500;
  • You have access
    Minimal clinically important difference in radiological progression of joint damage. A definition based on patient perspective.
    Paco M J Welsing, George F Borm and Piet van Riel
    The Journal of Rheumatology March 1 2006, 33 (3) 501-507;
  • You have access
    Loss of cortical bone from the metacarpal diaphysis in patients with rheumatoid arthritis: independent effects of systemic inflammation and glucocorticoids.
    José F Roldán, Inmaculada Del Rincón and Agustín Escalante
    The Journal of Rheumatology March 1 2006, 33 (3) 508-516;
  • You have access
    Cervical spine surgery in patients with rheumatoid arthritis: longterm mortality and its determinants.
    Antti Ronkainen, Minna Niskanen, Anu Auvinen, Jussi Aalto and Riitta Luosujärvi
    The Journal of Rheumatology March 1 2006, 33 (3) 517-522;
  • You have access
    Polymorphism of the FcgammaRIIalpha IgG receptor in patients with lupus nephritis and glomerulopathy.
    Adriana Peixoto Gelmetti, Antônio Carlos Freitas, Viktoria Woronik, Rui Toledo Barros, Eloísa Bonfá and Renato Costa Monteiro
    The Journal of Rheumatology March 1 2006, 33 (3) 523-530;
  • You have access
    Prevalence of neurocognitive dysfunction and other clinical manifestations in disabled patients with systemic lupus erythematosus.
    Tammy O Utset, Joseph Fink and Nicholas A Doninger
    The Journal of Rheumatology March 1 2006, 33 (3) 531-538;
  • You have access
    Increased concentration of proatherogenic inflammatory cytokines in systemic lupus erythematosus: relationship to cardiovascular risk factors.
    Yu Asanuma, Cecilia P Chung, Annette Oeser, Ayumi Shintani, Eran Stanley, Paolo Raggi and C Michael Stein
    The Journal of Rheumatology March 1 2006, 33 (3) 539-545;
  • You have access
    Proton magnetic resonance spectroscopy reveals central neuroaxonal impairment in systemic sclerosis.
    Luca Bertinotti, Marzia Mortilla, Maria Letizia Conforti, Nicola Colangelo, Francesca Nacci, Angela Del Rosso, Claudio Fonda, Roberto Casale, Marco Matucci-Cerinic and Alberto Pignone
    The Journal of Rheumatology March 1 2006, 33 (3) 546-551;
  • You have access
    Developing classification criteria for peripheral joint psoriatic arthritis. Step I. Establishing whether the rheumatologist's opinion on the diagnosis can be used as the "gold standard".
    Deborah P M Symmons, Mark Lunt, Gillian Watkins, Philip Helliwell, Sharon Jones, Neil McHugh and Douglas Veale
    The Journal of Rheumatology March 1 2006, 33 (3) 552-557;
  • You have access
    Prospective observational analysis of the efficacy and safety of low-dose (3 mg/kg) infliximab in ankylosing spondylitis: 4-year followup.
    Stephanie Keeling, Anna Oswald, Anthony S Russell and Walter P Maksymowych
    The Journal of Rheumatology March 1 2006, 33 (3) 558-561;
  • You have access
    Medication errors with the use of allopurinol and colchicine: a retrospective study of a national, anonymous Internet-accessible error reporting system.
    Ted R Mikuls, Jeffrey R Curtis, Jeroan J Allison, Rodney W Hicks and Kenneth G Saag
    The Journal of Rheumatology March 1 2006, 33 (3) 562-566;
  • You have access
    Pennsaid therapy for osteoarthritis of the knee: a systematic review and metaanalysis of randomized controlled trials.
    Tanveer E Towheed
    The Journal of Rheumatology March 1 2006, 33 (3) 567-573;
  • You have access
    Measurement of pain using the visual numeric scale.
    Philip L Ritter, Virginia M González, Diana D Laurent and Kate R Lorig
    The Journal of Rheumatology March 1 2006, 33 (3) 574-580;
  • You have access
    Assessing a whiplash management model: a population-based non-randomized intervention study.
    Samy Suissa, Marc Giroux, Marie Gervais, Pierre Proulx, Claire Desbiens, Joseph Austin Christopher Delaney, Jac Delaney, Jacqueline Quail, Brian Stevens and Sally Nikolaj
    The Journal of Rheumatology March 1 2006, 33 (3) 581-587;
  • You have access
    Utilization and cost comparison of current and optimal prescribing of nonsteroidal antiinflammatory drugs in Quebec, Canada.
    Elham Rahme, Youssef Toubouti and Jacques Lelorier
    The Journal of Rheumatology March 1 2006, 33 (3) 588-596;
  • You have access
    Comparison of clinical and laboratory variables in familial versus sporadic systemic onset juvenile idiopathic arthritis.
    Sulaiman M Al-Mayouf, Sana M Madi, Khalid AlMane and Suliman Al Jummah
    The Journal of Rheumatology March 1 2006, 33 (3) 597-600;
  • You have access
    Effect of inflammatory activity and glucocorticoid [corrected] use on nutritional variables in patients with juvenile idiopathic arthritis.
    Letícia Souza, Sandra Helena Machado, Markus Bredemeier, João Carlos Tavares Brenol and Ricardo Machado Xavier
    The Journal of Rheumatology March 1 2006, 33 (3) 601-608;
  • You have access
    Treatment of pediatric localized scleroderma with methotrexate.
    Pamela G Fitch, Patricia Rettig, Jon M Burnham, Terri H Finkel, Albert C Yan, Evren Akin and Randy Q Cron
    The Journal of Rheumatology March 1 2006, 33 (3) 609-614;
  • You have access
    Chondrocyte apoptosis and expression of Bcl-2, Bax, Fas, and iNOS in articular cartilage in patients with Kashin-Beck disease.
    Shi Jie Wang, Xiong Guo, Hong Zuo, Yin Gang Zhang, Peng Xu, Zhi Guang Ping, Zentie Zhang and Dong Geng
    The Journal of Rheumatology March 1 2006, 33 (3) 615-619;
  • You have access
    Laser induced chrysiasis: disfiguring hyperpigmentation following Q-switched laser therapy in a woman previously treated with gold.
    Hani Almoallim, Alice V Klinkhoff, Anne B Arthur, Jason K Rivers and Andrew Chalmers
    The Journal of Rheumatology March 1 2006, 33 (3) 620-621;
  • You have access
    Pulmonary complications of infliximab therapy in patients with rheumatoid arthritis.
    Andrew J K Ostör, Edwin R Chilvers, Margaret F Somerville, Anita Y N Lim, Suzanne E Lane, Adrian J Crisp and David G I Scott
    The Journal of Rheumatology March 1 2006, 33 (3) 622-628;
  • You have access
    Pantoprazole and perinuclear antineutrophil cytoplasmic antibody-associated vasculitis.
    Dana Jacobs-Kosmin, Chris T Derk and Nora Sandorfi
    The Journal of Rheumatology March 1 2006, 33 (3) 629-632;
  • You have access
    Supernumerary metatarsal bone.
    Francesco Borraccia, Mariella Montaruli, Giovanni Peruz and Ignazio Olivieri
    The Journal of Rheumatology March 1 2006, 33 (3) 633;
  • You have access
    Nonsystemic vasculitic neuropathy: a clinicopathological study of 22 cases.
    Peer M Aries and Wolfgang L Gross
    The Journal of Rheumatology March 1 2006, 33 (3) 636;
  • You have access
    Bilateral ocular myositis as a late complication of dermatomyositis.
    David T L Liu and Alice Y K Chan
    The Journal of Rheumatology March 1 2006, 33 (3) 637;
Back to top
PreviousNext

In this issue

The Journal of Rheumatology
Vol. 33, Issue 3
1 Mar 2006
  • Table of Contents
  • Index by Author
  • Most Read
  • ​ Editor's Picks
  • E-letters
Loading
  • Effects of Bedtime Very Low Dose Cyclobenzaprine on Symptoms and Sleep Physiology in Patients with Fibromyalgia Syndrome: A Double-blind Randomized Placebo-controlled Study
  • Management of Calcinosis Cutis in Rheumatic Diseases
  • Scleroderma-like Disease Due to Diffuse Monosodium Urate Crystal Deposition
  • Long-Term Safety and Efficacy of Ixekizumab in Patients With Axial Spondyloarthritis: 3-year Data From the COAST Program
  • Rat Bite Erosion of the Knee
More...

Content

  • First Release
  • Current
  • Archives
  • Collections
  • Audiovisual Rheum
  • COVID-19 and Rheumatology

Resources

  • Guide for Authors
  • Submit Manuscript
  • Author Payment
  • Reviewers
  • Advertisers
  • Classified Ads
  • Reprints and Translations
  • Permissions
  • Meetings
  • FAQ
  • Policies

Subscribers

  • Subscription Information
  • Purchase Subscription
  • Your Account
  • Terms and Conditions

More

  • About Us
  • Contact Us
  • My Alerts
  • My Folders
  • Privacy/GDPR Policy
  • RSS Feeds
The Journal of Rheumatology
The content of this site is intended for health care professionals.
Copyright © 2022 by The Journal of Rheumatology Publishing Co. Ltd.
Print ISSN: 0315-162X; Online ISSN: 1499-2752
Powered by HighWire